FTRE — Fortrea Holdings Inc.

Nasdaq · Health Care · Health Care Providers & Services · CIK 1965040 ·
Last close
$19.17
Market Cap
$1.82B
52W High
$21.39
52W Low
$11.48
ADV30
1,571,613
Next earnings
2026-07-29
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026
Mar 2026 636,500,000 123,600,000 3,300,000 -23,600,000 2,683,400,000 147,500,000 2,157,500,000
Dec 2025 660,500,000 131,100,000 8,800,000 -32,500,000 2,715,700,000 174,600,000 2,152,200,000
Sep 2025 701,300,000 122,700,000 -3,700,000 -15,900,000 2,742,100,000 131,300,000 2,161,300,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$220,700,000
Investing CF
$-9,700,000
Financing CF
$-164,700,000
CapEx
$-30,300,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-4.91
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,406,800,000
Inventory
Receivables
$619,600,000
ST Investments
EBIT TTM
$-359,100,000
Pretax Income TTM
$-447,300,000
Interest Exp TTM
$88,200,000
Analysts
11

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,676,499,968
EBITDA
$98,300,000
Free Cash Flow
$278,862,496
Enterprise Value
$2,763,707,904
Total Cash
$168,600,000
Total Debt
$1,117,799,936
Shares Out
95,100,000
Trailing EPS
$-0.83
Book Value
$5.56
ROE
-15.3%
ROA
0.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,723,400,000 -30,600,000 -986,200,000 2,715,700,000 2,152,200,000 113,500,000
Dec 2024 2,696,400,000 -111,800,000 -328,500,000 3,579,200,000 2,216,800,000 262,800,000
Dec 2023 2,842,500,000 53,200,000 -25,200,000 4,332,600,000 2,618,500,000 168,400,000
Dec 2022 2,837,000,000 222,800,000 186,200,000 4,287,900,000 945,300,000 82,700,000

TTM Snapshot

Revenues TTM
$2,138,500,000
NetIncome TTM
$-91,800,000
OpCashFlow TTM
$0
Assets (Latest)
$3,579,200,000
Forward EPS
$1.12

Max Pain — expiry 2026-08-21

max pain strike: $15.00 · spot: $19.17 · call oi: 6,551 · put oi: 488
Expected Move to 2026-08-21: ±$2.77 (14.48%) — implied range $16.40$21.95 · ATM straddle on $20.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SNDA SONIDA SENIOR LIVING, INC. $1.91B $40.36
WGS GeneDx Holdings Corp. $1.93B $65.11
SGRY Surgery Partners, Inc. $2.01B $15.40
AVAH Aveanna Healthcare Holdings, Inc. $2.04B $9.39
HCSG HEALTHCARE SERVICES GROUP INC $1.60B $23.30

News headlines (Yahoo Finance, 1h cache)

Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here's What You Should Know
2026-07-31 16:00 · Yahoo
FTRE vs. ARGX: Which Stock Is the Better Value Option?
2026-07-31 15:40 · Yahoo
Best Momentum Stock to Buy for July 31st
2026-07-31 14:00 · Yahoo
Fortrea Holdings Inc (FTRE) Q2 2026 Earnings Call Highlights: Strong Revenue Guidance Amid ...
2026-07-29 19:01 · Yahoo
Fortrea Q2 Earnings Call Highlights
2026-07-29 15:04 · Yahoo
Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates
2026-07-29 12:25 · Yahoo
Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full-Year Sales Guidance is Optimistic
2026-07-29 10:41 · Yahoo
Fortrea Reports Second Quarter 2026 Results
2026-07-29 10:30 · Yahoo
Fortrea Earnings: What To Look For From FTRE
2026-07-28 16:45 · Yahoo
3 Reasons to Sell FTRE and 1 Stock to Buy Instead
2026-07-17 15:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.